Ana P. Ortiz to Papillomavirus Vaccines
This is a "connection" page, showing publications Ana P. Ortiz has written about Papillomavirus Vaccines.
Connection Strength
0.875
-
Cruz A, Ramos-Cartagena JM, Panicker G, P?rez CM, Su?rez E, Romaguera J, Unger ER, Rivera T, Ortiz AP. Seroprevalence of nine human papillomavirus types included in the nonavalent vaccine in unvaccinated women living in Puerto Rico: A population-based study. Int J Infect Dis. 2026 Feb; 163:108195.
Score: 0.763
-
Ortiz AP, Tortolero-Luna G, Romaguera J, P?rez CM, Gonz?lez D, Mu?oz C, Gonz?lez L, Marrero E, Su?rez E, Palefsky JM, Panicker G, Unger ER. Seroprevalence of HPV 6, 11, 16 and 18 and correlates of exposure in unvaccinated women aged 16-64 years in Puerto Rico. Papillomavirus Res. 2018 06; 5:109-113.
Score: 0.112